SENNA-S- docusate sodium and sennosides tablet, film coated 
Goldline Laboratories, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

SENNA-S

Drug Facts

Active ingredients
(in each tablet)
Purposes
Docusate sodium 50 mgStool softener
Sennosides 8.6 mgStimulant laxative

Uses

  • relieves occasional constipation (irregularity)
  • generally causes a bowel movement in 6 to 12 hours

Warnings

Do not use

  • this product if you are presently taking mineral oil, unless directed by a doctor
  • laxative products for more than 1 week unless directed by a doctor

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomiting
  • a sudden change in bowel habits that persists over 2 weeks

Stop use and ask a doctor if you

  • have rectal bleeding
  • fail to have a bowel movement after the use of a laxative

These could be signs of a serious condition

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

  • take preferably at bedtime or as directed by a doctor
  • if you do not have a comfortable bowel movement by the second day, increase dose by one tablet (do not exceed maximum dosage); or decrease dose until you are comfortable
agestarting dosemaximum dose
adults and children 12 years and over2 tablets once a day4 tablets twice a day
children 6 to under 12 years1 tablet once a day2 tablets twice a day
children 2 to under 6 years1/2 tablet once a day1 tablet twice a day
children under 2 yearsask a doctorask a doctor

Other information

  • each tablet contains: calcium 20 mg, sodium 6 mg (LOW SODIUM)
  • TAMPER-EVIDENT: Do not use this product if imprinted foil seal over the mouth of the bottle is cut, torn, broken or missing
  • store at 25°C (77°F) excursions permitted between 15°-30°C (59°-86°F)

Inactive ingredients

carnauba wax, colloidal silicon dioxide, croscarmellose sodium, dibasic calcium phosphate dihydrate, D&C yellow #10 aluminum lake, FD&C yellow #6 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium benzoate, stearic acid, titanium dioxide

Questions?

call 1-888-838-2872, weekdays, 8 AM-5 PM Eastern Time

Distributed by:
GOLDLINE LABORATORIES, INC.
Sellersville, PA 18960 Dist. 1999 0711REV 89
192B R0711

PRINCIPAL DISPLAY PANEL

Senna-S Tablets 1000s Label

Senna-S Tablets 1000s Label Text

Goldline®

NDC 0182-1113-10
TAMPER-EVIDENT

SENNA-S
TABLETS

(brand of Standardized Senna Concentrate
Equivalent to 8.6 mg Sennosides
and Docusate Sodium 50 mg)

NATURAL VEGETABLE STIMULANT LAXATIVE
AND STOOL SOFTENER

THIS PACKAGE FOR HOUSEHOLDS
WITHOUT YOUNG CHILDREN

1000 TABLETS

SENNA-S 
docusate sodium and sennosides tablet, film coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0182-1113
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM50 mg
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
Inactive Ingredients
Ingredient NameStrength
CARNAUBA WAX (UNII: R12CBM0EIZ)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE (UNII: O7TSZ97GEP)  
D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  
ALUMINUM OXIDE (UNII: LMI26O6933)  
FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A)  
SODIUM BENZOATE (UNII: OJ245FE5EU)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
Product Characteristics
ColorORANGEScoreno score
ShapeROUND (bi-convex) Size10mm
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0182-1113-101000 in 1 BOTTLE, PLASTIC
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33403/23/199910/31/2016
Labeler - Goldline Laboratories, Inc. (032349292)

Revised: 7/2014
 
Goldline Laboratories, Inc.